Skip to main content
B

Biotwin

BioTwin develops a virtual twin technology that utilizes biomarker data to create personalized health simulations, enabling predictive and preventive healthcare. This approach addresses the challenge of inaccurate diagnostics and unnecessary medical procedures by allowing clinicians to test treatment options and predict patient responses before actual interventions.

Québec, CanadaFounded 2020182K+ followers
Updated 4 months ago

Funding

$8.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current diagnostic methods often rely on incomplete patient information, leading to inaccurate diagnoses, over-testing, unnecessary procedures, and increased healthcare costs. Screening for diseases is expensive, time-consuming, and can be potentially harmful to patients.

Solution

BioTwin offers a virtual twin technology that leverages biological biomarker data to create personalized health simulations, enabling predictive and preventive healthcare. By tracking key biomarkers, including metabolites, lipids, and proteins, BioTwin creates a virtual representation of a patient's health status. This virtual twin allows clinicians to simulate treatment options, predict patient responses to medication, identify potential complications, and facilitate early disease detection. The platform aims to make healthcare more accessible, convenient, affordable, and risk-free by eliminating redundancy and empowering individuals to reach their full health potential.

Target Audience

BioTwin primarily targets clinicians and health professionals seeking to improve diagnostic accuracy, reduce healthcare costs, and provide personalized, preventive care to their patients.

Features

  • At-home biomarker collection kits for convenient sample acquisition
  • Integration with third-party wellness applications for comprehensive data aggregation
  • Virtual simulations to test treatment options and predict patient responses
  • Identification of potential health complications before they arise
  • Early detection of various health conditions through pattern recognition
  • Personalized healthcare recommendations based on individual biomarker profiles
This profile is AI-generated and may contain inaccuracies.